BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 7680382)

  • 21. Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker.
    Nosotti M; Falleni M; Palleschi A; Pellegrini C; Alessi F; Bosari S; Santambrogio L
    Chest; 2005 Sep; 128(3):1539-44. PubMed ID: 16162755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of Cancer and Leukemia Group B Trial 9761.
    D'Cunha J; Corfits AL; Herndon JE; Kern JA; Kohman LJ; Patterson GA; Kratzke RA; Maddaus MA
    J Thorac Cardiovasc Surg; 2002 Mar; 123(3):484-91; discussion 491. PubMed ID: 11882819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in "node-negative" colorectal cancer.
    Sasaki M; Watanabe H; Jass JR; Ajioka Y; Kobayashi M; Matsuda K; Hatakeyama K
    J Gastroenterol; 1997 Dec; 32(6):758-64. PubMed ID: 9430013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of occult micrometastases in non-small cell lung carcinoma by reverse transcriptase-polymerase chain reaction.
    Salerno CT; Frizelle S; Niehans GA; Ho SB; Jakkula M; Kratzke RA; Maddaus MA
    Chest; 1998 Jun; 113(6):1526-32. PubMed ID: 9631789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of occult tumor cells in lymph nodes from non-small cell lung cancer patients using reverse transcription-polymerase chain reaction for carcinoembryonic antigen mRNA with the evaluation of its sensitivity.
    Maeda J; Inoue M; Okumura M; Ohta M; Minami M; Shiono H; Shintani Y; Matsuda H; Matsuura N
    Lung Cancer; 2006 May; 52(2):235-40. PubMed ID: 16510209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance.
    Dobashi K; Sugio K; Osaki T; Oka T; Yasumoto K
    J Thorac Cardiovasc Surg; 1997 Sep; 114(3):339-46. PubMed ID: 9305185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of p53 alterations in occult lymph node metastases.
    Maruyama R; Sugio K; Fukuyama Y; Hamatake M; Sakada T; Saitoh G; Sugimachi K
    J Surg Oncol; 2000 Mar; 73(3):143-7. PubMed ID: 10738267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival.
    Greenson JK; Isenhart CE; Rice R; Mojzisik C; Houchens D; Martin EW
    Cancer; 1994 Feb; 73(3):563-9. PubMed ID: 7507795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.
    Takeshita T; Tsuda H; Moriya T; Yamasaki T; Asakawa H; Ueda S; Sato K; Aida S; Tamai S; Matsubara O; Hase K; Yamamoto J
    Ann Surg Oncol; 2012 Apr; 19(4):1160-6. PubMed ID: 21989659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study.
    Dowlatshahi K; Fan M; Bloom KJ; Spitz DJ; Patel S; Snider HC
    Cancer; 1999 Sep; 86(6):990-6. PubMed ID: 10491525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
    Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
    Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
    Reed W; Bøhler PJ; Sandstad B; Nesland JM
    Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical detection of lymph node micrometastases from gallbladder carcinoma using monoclonal anticytokeratin antibody.
    Yokoyama N; Shirai Y; Hatakeyama K
    Cancer; 1999 Apr; 85(7):1465-9. PubMed ID: 10193935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of pathologist-detected and automated computer-assisted image analysis detected sentinel lymph node micrometastases in breast cancer.
    Weaver DL; Krag DN; Manna EA; Ashikaga T; Harlow SP; Bauer KD
    Mod Pathol; 2003 Nov; 16(11):1159-63. PubMed ID: 14614056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for occult nodal metastasis in squamous cell carcinoma of the vulva.
    Leys CM; Hartenbach EM; Hafez GR; Mahvi DM
    Int J Gynecol Pathol; 2000 Jul; 19(3):243-7. PubMed ID: 10907173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The significance of immunohistochemically demonstrated nodal micrometastases in patients with squamous cell carcinoma of the head and neck.
    Rhee D; Wenig BM; Smith RV
    Laryngoscope; 2002 Nov; 112(11):1970-4. PubMed ID: 12439164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel node mapping and micrometastasis in patients with clinical stage IA non-small cell lung cancer.
    Ono T; Minamiya Y; Ito M; Saito H; Motoyama S; Nanjo H; Ogawa J
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):659-61. PubMed ID: 19643803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraoperative, radio-guided sentinel lymph node mapping in 110 nonsmall cell lung cancer patients.
    Rzyman W; Hagen OM; Dziadziuszko R; Kobierska-Gulida G; Karmolinski A; Lothe IM; Babovic A; Murawski M; Paleczka W; Jastrzebski T; Kopacz A; Jassem J; Lass P; Skokowski J
    Ann Thorac Surg; 2006 Jul; 82(1):237-42. PubMed ID: 16798221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pragmatic approach to the diagnosis of nodal micrometastases in early stage non-small cell lung cancer.
    Herpel E; Muley T; Schneider T; Palm E; Kieslich de Hol D; Warth A; Meister M; Storz K; Schnabel PA; Schirmacher P; Dienemann H; Hoffmann H
    J Thorac Oncol; 2010 Aug; 5(8):1206-12. PubMed ID: 20581709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The presence of isolated tumor cells and micrometastases in the intrathoracic lymph nodes of patients with lung cancer is not associated with decreased survival.
    Marchevsky AM; Gupta R; Kusuanco D; Mirocha J; McKenna RJ
    Hum Pathol; 2010 Nov; 41(11):1536-43. PubMed ID: 20656322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.